Greece
Alzheimer Hellas
The Greek Association of Alzheimer’s Disease and Related Disorders (Alzheimer Hellas) is a non-profit organisation, founded in 1995 by relatives of patients with Alzheimer’s Disease and doctors of all specialties. It operates three (3) Day Care Centers in Greece, a Day centre for caregivers, a Home-care unit, and an inpatient facility for End-stage Dementia patients. Since 2000, Alzheimer Hellas has organised fourteen (14) Pan-Hellenic Interdisciplinary Conferences, along with informative lectures and seminars.
With over 5,000 members, it focuses on fight stigma associated with neurodegenerative diseases, and control behavioural and affective disorders, and providing non-pharmacological interventions and appropriate medical care from specialised health care professionals
Website
Germany
Zentralinstitut für Seelische Gesundheit
The Central Institute of Mental Health stands at the forefront of global research and pioneering treatments across various domains of mental health, including psychiatry, psychotherapy, child and adolescent psychiatry, psychosomatic medicine, and addiction medicine. With four clinics strategically located in Mannheim, they ensure comprehensive psychiatric care for individuals of all age groups. Renowned as one of the premier institutions in psychiatric research in Europe, their commitment is evident through a dedicated team of over 1,400 employees. As they consistently expand their capacities, the institute remains at the forefront of innovation, creating new avenues for groundbreaking research and delivering compassionate treatment to those in need.
Website
Finland
UNIVERSITY OF EASTERN FINLAND
The Brain Research Unit (BRU) at the School of Medicine, Faculty of Health Sciences, UEF has experience in conducting dementia-related clinical trials since 1992. Clinical studies at the UEF BRU include e.g. Finnish and multi-national randomized controlled pharmacological and non-pharmacological intervention studies, epidemiological population-based studies, and memory clinic-based studies, both industry- and academia-funded. The UEF BRU biomarker laboratory has over 20 years’ experience in clinical development and testing of biomarkers for dementia diseases. Since 2005 it provides a national biomarker laboratory service available for physicians and hospitals. The quality management system is based on international standards for quality management and for clinical laboratories. It has been audited by laboratory professionals from another testing laboratory and internal audits are done according to the audit program of UEF. The laboratory also takes part in several large-scale international studies on AD fluid biomarkers. In addition to researchers, the dedicated team of professionals at the UEF BRU includes physicians, nurses, neuropsychologists and other research personnel.
The UEF BRU works together with the memory clinic at Kuopio University Hospital. The 2D-BioPAD UEF team also reflects the close collaboration between the BRU and the Neuro-Ethics and Law Research Group at the School of Law, Faculty of Social Sciences and Business Studies.
